Open AccessATIM-27. PHASE I INVESTIGATION OF LENALIDOMIDE PLUS RITUXIMAB AND OUTCOMES OF LENALIDOMIDE MAINTENANCE IN RECURRENT CNS LYMPHOMA
Neuro-oncologyPeer ReviewedJames L. Rubenstein +112016Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support